Gene: FUT11
Official Full Name: fucosyltransferase 11provided by HGNC
Gene Summary: Enables fucosyltransferase activity. Involved in N-glycan fucosylation. Predicted to be located in Golgi cisterna membrane and Golgi membrane. Implicated in stomach cancer. Biomarker of stomach cancer. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17515 | FUT11 Knockout cell line (HeLa) | Human | FUT11 | 1:3~1:6 | Negative | Online Inquiry |
KO17516 | FUT11 Knockout cell line (HCT 116) | Human | FUT11 | 1:2~1:4 | Negative | Online Inquiry |
KO17517 | FUT11 Knockout cell line (HEK293) | Human | FUT11 | 1:3~1:6 | Negative | Online Inquiry |
KO17518 | FUT11 Knockout cell line (A549) | Human | FUT11 | 1:3~1:4 | Negative | Online Inquiry |
FUT11 Gene Knockout Cell Lines are specialized cellular models engineered to specifically lack the FUT11 gene, a critical player in the synthesis of certain fucosylated glycoconjugates. Fucosylation is vital in various biological processes, including cell recognition, adhesion, and signaling. By knocking out the FUT11 gene, these cell lines provide researchers with a robust tool to elucidate the roles of fucosylated compounds in cellular biology and disease.
The key mechanism of action for these knockout cell lines involves targeted gene editing, typically achieved through CRISPR/Cas9 technology or RNA interference techniques, leading to complete abrogation of FUT11 expression. This gene knockout alters the fucosylation pattern on glycoproteins and glycolipids, facilitating detailed studies on their functional impacts in various biological contexts, such as immune response modulation, cancer metastasis, and pathogen-host interactions.
Scientifically, FUT11 Gene Knockout Cell Lines are invaluable in research settings focused on glycoscience, immunology, cancer biology, and microbiology. They enable the dissection of specific fucosylation pathways, leading to a deeper understanding of how these modifications influence health and disease. In clinical applications, these models can aid in the development of therapeutics that target fucosylation processes.
What sets our FUT11 Gene Knockout Cell Lines apart is their precision and reliability. Compared to conventional methods that may produce off-target effects or variable fucosylation patterns, our knockout cell lines ensure consistent and reproducible results, enhancing the rigor of experimental findings. For researchers and clinicians alike, this translates into confident data interpretation and the potential for translational applications.
With years of expertise in bioengineering and cell line development, our company is dedicated to equipping the scientific community with high-quality biological products such as the FUT11 Gene Knockout Cell Lines, designed to advance research and foster breakthrough discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.